Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study.

Huang, Shirley P; Guisinger, Amy; Averell, Carlyne; Bell, Christopher F; Rubin, Bernie

Huang, Shirley P; Guisinger, Amy; Averell, Carlyne; Bell, Christopher F; Rubin, Bernie.

Afiliação

Huang SP; GSK, US Value, Evidence and Outcomes, Durham, NC, USA.
Guisinger A; GSK, US Value, Evidence and Outcomes, Durham, NC, USA.
Averell C; GSK, US Value, Evidence and Outcomes, Durham, NC, USA.
Bell CF; GSK, US Value, Evidence and Outcomes, Durham, NC, USA. christopher.f.bell@gsk.com.
Rubin B; GSK, US Medical Affairs, Immuno-Inflammation, Durham, NC, USA.

Rheumatol Ther ; 10(3): 551-562, 2023 Jun.

Article em En | MEDLINE | ID: mdl-36738424

Palavras-chave

Cost of illness; Health services research; Lupus erythematosus, systemic; Lupus nephritis; Therapeutics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google